TMB-high advanced neoplasms research hub

Pilot study with Low-dose nivolumab in Advanced Neoplasms that are TMB-high

This early-stage study tests whether a lower dose of an immunotherapy drug called nivolumab can treat advanced cancers with many genetic changes, known as TMB-high tumours. Researchers want to see if this lower dose works well to shrink tumours while keeping side effects as low as possible.